Biotechnology in the Netherlands

Date: February 12, 2015
Pages: 33
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B792EF71376EN
Leaflet:

Download PDF Leaflet

Biotechnology in the Netherlands
INTRODUCTION

Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

HIGHLIGHTS
  • The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
  • The Dutch biotechnology industry had total revenues of $352.1m in 2014, representing a compound annual growth rate (CAGR) of 0.8% between 2010 and 2014.
  • The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $265m, equivalent to 75.3% of the industry's overall value.
  • The performance of the industry is forecast to accelerate, with an anticipated CAGR of 4.7% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $441.9m by the end of 2019.
FEATURES
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in the Netherlands
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the Netherlands
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands biotechnology market with five year forecasts
  • Macroeconomic indicators provide insight into general trends within the Netherlands economy
KEY QUESTIONS ANSWERED
  • What was the size of the Netherlands biotechnology market by value in 2014?
  • What will be the size of the Netherlands biotechnology market in 2019?
  • What factors are affecting the strength of competition in the Netherlands biotechnology market?
  • How has the market performed over the last five years?
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Actelion Ltd
AstraZeneca PLC
Biogen Idec, Inc.
Crucell N.V.
Macroeconomic Indicators
Country Data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table: Netherlands biotechnology industry value: $ million(e)
Table: Netherlands biotechnology industry category segmentation: $ million, (e)
Table: Netherlands biotechnology industry geography segmentation: $ million, (e)
Table: Netherlands biotechnology industry value forecast: $ million
Table: Actelion Ltd: key facts
Table: Actelion Ltd: key financials ($)
Table: Actelion Ltd: key financials (CHF)
Table: Actelion Ltd: key financial ratios
Table: AstraZeneca PLC: key facts
Table: AstraZeneca PLC: key financials ($)
Table: AstraZeneca PLC: key financial ratios
Table: Biogen Idec, Inc.: key facts
Table: Biogen Idec, Inc.: key financials ($)
Table: Biogen Idec, Inc.: key financial ratios
Table: Crucell N.V.: key facts
Table: Netherlands size of population (million)
Table: Netherlands gdp (constant prices, $ billion)
Table: Netherlands gdp (current prices, $ billion)
Table: Netherlands inflation
Table: Netherlands consumer price index (absolute)
Table: Netherlands exchange rate

LIST OF FIGURES

Figure: Netherlands biotechnology industry value: $ million(e)
Figure: Netherlands biotechnology industry category segmentation: % share, by value, (e)
Figure: Netherlands biotechnology industry geography segmentation: % share, by value, (e)
Figure: Netherlands biotechnology industry value forecast: $ million
Figure: Forces driving competition in the biotechnology industry in the Netherlands,
Figure: Drivers of buyer power in the biotechnology industry in the Netherlands,
Figure: Drivers of supplier power in the biotechnology industry in the Netherlands,
Figure: Factors influencing the likelihood of new entrants in the biotechnology industry in the Netherlands,
Figure: Factors influencing the threat of substitutes in the biotechnology industry in the Netherlands,
Figure: Drivers of degree of rivalry in the biotechnology industry in the Netherlands,
Figure: Actelion Ltd: revenues & profitability
Figure: Actelion Ltd: assets & liabilities
Figure: AstraZeneca PLC: revenues & profitability
Figure: AstraZeneca PLC: assets & liabilities
Figure: Biogen Idec, Inc.: revenues & profitability
Figure: Biogen Idec, Inc.: assets & liabilities


Skip to top


Ask Your Question

Biotechnology in the Netherlands
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: